ACTIVE

PHARMA-LOUVE

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

110,7 k €

-3.9% YoY

Gross margin

395,9 k €

-3.7% YoY

Equity

1,1 M €

+11.5% YoY

Workforce

2,6 ETP

0.0% YoY

What does PHARMA-LOUVE do?

PHARMA-LOUVE is a Private limited company incorporated in 2007. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Seneffe. It employs on average 2,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0894.160.549

Incorporation

13/12/2007

Legal form

Private limited company

Registered office

Rue des Canadiens 24
7180 Seneffe · WallonieSee on map

Contributed capital

375 000,00 €

Latest accounts

31/12/2025

Average workforce

2,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008
Income statement
Gross margin	395,9 k €	-3.7%	410,9 k €	+19.0%	345,3 k €	-3.4%	357,5 k €	-9.9%	396,7 k €	+11.9%	354,6 k €	+6.2%	333,9 k €	+8.9%	306,6 k €	+16.3%	263,6 k €	+7.2%	245,8 k €	+25.7%	195,6 k €	-55.2%	436,8 k €	-4.2%	456 k €	+14.6%	397,8 k €	-3.7%	412,9 k €	-6.7%	442,4 k €	+21.2%	364,9 k €	+163%	138,8 k €
EBITDA	197,3 k €	-13.4%	227,9 k €	+36.5%	167 k €	-12.1%	190 k €	-21.6%	242,3 k €	+13.3%	214 k €	+11.0%	192,8 k €	+33.3%	144,6 k €	+9.5%	132,1 k €	+10.0%	120,1 k €	+61.3%	74,4 k €	+101%	37,1 k €	-77.7%	166,2 k €	+43.0%	116,2 k €	-21.5%	148 k €	-7.3%	159,7 k €	+26.4%	126,3 k €	+1122%	-12,4 k €
Operating result	152 k €	-4.7%	159,5 k €	+60.7%	99,2 k €	-21.6%	126,6 k €	-34.8%	194 k €	+29.9%	149,3 k €	+16.6%	128,1 k €	+62.7%	78,7 k €	+193%	26,9 k €	+44.2%	18,7 k €	+233%	-14 k €	+21.7%	-18 k €	-116%	112,8 k €	+73.9%	64,8 k €	-11.5%	73,3 k €	-7.4%	79,1 k €	+83.2%	43,2 k €	+144%	-98,8 k €
Net result	110,7 k €	-3.9%	115,3 k €	+70.1%	67,8 k €	-23.5%	88,6 k €	-41.4%	151,1 k €	+43.8%	105,1 k €	+30.4%	80,6 k €	+46.9%	54,9 k €	+226%	16,8 k €	+109%	8 k €	+126%	-30,8 k €	-70.1%	-18,1 k €	-124%	74,4 k €	+78.3%	41,7 k €	-29.2%	59 k €	-11.0%	66,2 k €	+193%	22,6 k €	+123%	-98,9 k €
Balance sheet
Equity	1,1 M €	+11.5%	964,4 k €	+13.6%	849,1 k €	+8.7%	781,3 k €	+12.8%	692,8 k €	+17.1%	591,6 k €	+21.6%	486,5 k €	+19.9%	405,9 k €	-21.3%	516 k €	+3.4%	499,2 k €	+1.6%	491,1 k €	-5.9%	521,9 k €	-3.4%	540,1 k €	+16.0%	465,7 k €	+9.8%	423,9 k €	+16.2%	365 k €	+22.2%	298,7 k €	+8.2%	276,1 k €
Total assets	1,5 M €	+9.0%	1,4 M €	+3.6%	1,4 M €	+5.3%	1,3 M €	+0.1%	1,3 M €	+6.4%	1,2 M €	+9.0%	1,1 M €	+3.9%	1,1 M €	-5.7%	1,1 M €	-1.4%	1,2 M €	-2.5%	1,2 M €	+2.8%	1,2 M €	-7.2%	1,3 M €	+5.1%	1,2 M €	-2.3%	1,2 M €	-4.5%	1,3 M €	-0.6%	1,3 M €	+4.6%	1,2 M €
Cash	648,9 k €	+46.7%	442,4 k €	+44.1%	307,1 k €	+26.9%	242 k €	-32.8%	360,3 k €	-4.9%	378,7 k €	+72.9%	219,1 k €	+118%	100,5 k €	-40.0%	167,4 k €	+112%	79 k €	-15.7%	93,8 k €	-76.5%	399,6 k €	-10.6%	446,7 k €	+35.3%	330,2 k €	+22.6%	269,4 k €	+2.5%	262,9 k €	+42.7%	184,2 k €	+252%	52,4 k €
Debts	474,9 k €	+3.7%	458,1 k €	-12.6%	524,1 k €	+0.3%	522,5 k €	-14.2%	609,2 k €	-3.7%	632,4 k €	-0.7%	636,6 k €	-5.8%	675,5 k €	+7.2%	630,2 k €	-5.0%	663,2 k €	-5.5%	701,5 k €	+18.9%	590,1 k €	-16.7%	708,1 k €	-2.2%	724 k €	-8.8%	793,8 k €	-12.2%	904,4 k €	-8.1%	984 k €	+3.7%	949,2 k €
Other
Workforce	2,6 ETP	0.0%	2,6 ETP	-3.7%	2,7 ETP	+3.8%	2,6 ETP	-3.7%	2,7 ETP	+8.0%	2,5 ETP	0.0%	2,5 ETP	-16.7%	3,0 ETP	+25.0%	2,4 ETP	+9.1%	2,2 ETP	+4.8%	2,1 ETP	-67.2%	6,4 ETP	+3.2%	6,2 ETP	-1.6%	6,3 ETP	-6.0%	6,7 ETP	+8.1%	6,2 ETP	+24.0%	5,0 ETP	+38.9%	3,6 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 23 ended

Active mandates

DEVANTHINIC PHARMA

Director · since 31 décembre 2014 · 0506.893.294

Represented by Anne André

Active

Ended mandates

DEVANTHINIC PHARMA

Managing director · since 31 décembre 2014 · 0506.893.294

Represented by ANNE ANDRE

Ended

DEVANTHINIC PHARMA

Managing director · since 31 décembre 2014 · 0506.893.294

Represented by ANNE ANDRE

Ended

DEVANTHINIC PHARMA

Director · since 31 décembre 2014 · 0506.893.294

Represented by Anne André

Ended

Stephane MERCIER

Director · since 01 août 2014 · until 31 décembre 2014

Ended

At this address

Other companies at this address

Company	CBE no.
DEVANTHINIC IMMO● Active	1039.753.688
DEVANTHINIC PHARMA● Active	0506.893.294
MARIEC.C-PHARMA● Active	0507.640.788
PHAMALIMO● Active	0846.675.386
PHARMACIE ANNE ANDRE● Active	0478.484.667
PHARMACIE DE BASCOUP● Active	0458.492.472
PHARMACIE DE BOIS-D'HAINE● Active	0432.058.190
PHARMACIE DE LA DRÊVE● Active	0421.582.883
PHARMACIE DE LA GRAND RUE● Active	0846.815.047
PHARMACIE DE LA VILLE BASSE● Active	0872.063.652
PHARMACIE SENEFFE CENTRE● Active	0477.710.053

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	24/08/2026	04/09/2025	29/08/2024	31/07/2023	26/08/2022	30/08/2021
General meeting	31/07/2026	31/07/2025	31/07/2024	30/06/2023	30/06/2022	29/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	31/07/2026	24/08/2026	French	PDF
Abridged modelCorrection	31/12/2024	31/07/2025	04/09/2025	French	PDF
Abridged model	31/12/2024	31/07/2025	25/08/2025	French	PDF
Abridged model	31/12/2023	31/07/2024	29/08/2024	French	PDF
Abridged model	31/12/2022	30/06/2023	31/07/2023	French	PDF
Abridged model	31/12/2021	30/06/2022	26/08/2022	French	PDF
Abridged model	31/12/2020	29/06/2021	30/08/2021	French	PDF
Abridged model	31/12/2019	30/06/2020	05/10/2020	French	PDF
Abridged model	31/12/2018	29/06/2019	07/04/2020	French	PDF
Abridged model	31/12/2017	30/06/2018	13/07/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	09/08/2017	French	PDF
Abridged model	31/12/2015	30/06/2016	17/08/2016	French	PDF
Abridged model	31/12/2014	30/06/2015	18/08/2015	French	PDF
Abridged model	31/12/2013	19/06/2014	27/06/2014	French	PDF
Abridged model	31/12/2012	18/06/2013	24/06/2013	French	PDF
Abridged model	31/12/2011	01/06/2012	27/06/2012	French	PDF
Abridged model	31/12/2010	30/05/2011	29/06/2011	French	PDF
Abridged model	31/12/2009	06/05/2010	03/06/2010	French	PDF
Abridged model	31/12/2008	02/06/2009	30/06/2009	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 23 ended

Active mandates

DEVANTHINIC PHARMA

Director · since 31 décembre 2014 · 0506.893.294

Represented by Anne André

Active

Ended mandates

DEVANTHINIC PHARMA

Managing director · since 31 décembre 2014 · 0506.893.294

Represented by ANNE ANDRE

Ended

DEVANTHINIC PHARMA

Managing director · since 31 décembre 2014 · 0506.893.294

Represented by ANNE ANDRE

Ended

DEVANTHINIC PHARMA

Director · since 31 décembre 2014 · 0506.893.294

Represented by Anne André

Ended

Stephane MERCIER

Director · since 01 août 2014 · until 31 décembre 2014

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates09/09/2022
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Mandates05/07/2021
DEMISSIONS, NOMINATIONS
PDF
Registered office20/03/2015
SIEGE SOCIAL
PDF
Mandates02/02/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates27/01/2015
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates25/07/2014
DEMISSIONS, NOMINATIONS
PDF
Mandates26/05/2014
DEMISSIONS, NOMINATIONS - COMPTES ANNUELS
PDF
Mandates23/06/2010
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025110,7 k €↓
2024
Annual accounts 2024115,3 k €↑
2023
Annual accounts 202367,8 k €↓
2023
Name changePHARMA-LOUVE
2022
Annual accounts 202288,6 k €↓
2021
Annual accounts 2021151,1 k €↑
2021
Name changePHARMALOUVE
2020
Annual accounts 2020105,1 k €↑
2019
Annual accounts 201980,6 k €↑
2018
Annual accounts 201854,9 k €↑
2017
Annual accounts 201716,8 k €↑
2016
Annual accounts 20168 k €↑
2015
Annual accounts 2015-30,8 k €↓
2014
Annual accounts 2014-18,1 k €↓
2013
Annual accounts 201374,4 k €↑
2012
Annual accounts 201241,7 k €↓
2011
Annual accounts 201159 k €↓
2010
Annual accounts 201066,2 k €↑
2009
Annual accounts 200922,6 k €↑
2008
Annual accounts 2008-98,9 k €
13/12/2007
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMA-LOUVE

Overview

What does PHARMA-LOUVE do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline